Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]

MeSH terms

• Diabetes Mellitus, Type 1 / drug therapy*
• Diabetes Mellitus, Type 2 / drug therapy*
• Dose-Response Relationship, Drug
• Humans
• Hypoglycemic Agents / adverse effects
• Hypoglycemic Agents / therapeutic use*
• Insulin / adverse effects*
• Insulin / analogs & derivatives
• Insulin / therapeutic use*
• Neoplasms / chemically induced*
• Neoplasms / epidemiology*
• Patient Selection
• Risk Assessment
• Risk Factors